Ignite Creation Date:
2024-05-06 @ 10:59 AM
Last Modification Date:
2024-10-26 @ 12:38 PM
Study NCT ID:
NCT03400735
Status:
UNKNOWN
Last Update Posted:
2018-01-17
First Post:
2016-10-03
Brief Title:
Comparison of Cefdinir and CefdinirClavulanic Acid Combination in Adults
Sponsor:
Neutec Ar-Ge San ve Tic AŞ
Organization:
Neutec Ar-Ge San ve Tic AŞ
Study Overview
Official Title:
Comparison of Cefdinir and CefdinirClavulanic Acid Combination in Treatment of Acute Exacerbation of Chronic Bronchitis AECB and Community-acquired Pneumonia CAP in Adults
Status:
UNKNOWN
Status Verified Date:
2018-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
It is planned to compare the efficacy and safety of cefdinir and cefdinirclavulanic acide treatments in acute exacerbation of chronic bronchitis AECB and community-acquired pneumoniae CAP patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None